Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,237 | 392 | 92.7% |
| Education | $807.84 | 15 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,415 | 81 | $0 (2024) |
| Coloplast Corp | $1,104 | 17 | $0 (2023) |
| Janssen Biotech, Inc. | $776.21 | 47 | $0 (2024) |
| PFIZER INC. | $750.37 | 49 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $688.12 | 10 | $0 (2024) |
| Boston Scientific Corporation | $674.31 | 7 | $0 (2019) |
| Teleflex LLC | $517.04 | 5 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $455.45 | 8 | $0 (2024) |
| Allergan, Inc. | $379.39 | 15 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $341.38 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,408 | 56 | Sumitomo Pharma America, Inc. ($295.71) |
| 2023 | $1,198 | 39 | Teleflex LLC ($367.50) |
| 2022 | $835.18 | 37 | Astellas Pharma US Inc ($286.14) |
| 2021 | $271.46 | 18 | Astellas Pharma US Inc ($64.77) |
| 2020 | $368.77 | 15 | Allergan, Inc. ($158.54) |
| 2019 | $2,401 | 86 | Ferring Pharmaceuticals Inc. ($486.53) |
| 2018 | $2,219 | 78 | Astellas Pharma US Inc ($376.75) |
| 2017 | $2,343 | 78 | Coloplast Corp ($411.63) |
All Payment Transactions
407 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Urology Gynecology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: HORMONE THERAPY | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: UROLOGY | ||||||
| 11/25/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/22/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/18/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Urology | ||||||
| 11/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: HORMONE THERAPY | ||||||
| 11/04/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/25/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Oncology | ||||||
| 10/18/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: HORMONE THERAPY | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), PIPELINE | Food and Beverage | In-kind items and services | $35.40 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $103.79 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Urology Gynecology | ||||||
| 08/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: UROLOGY | ||||||
| 08/20/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: HORMONE THERAPY | ||||||
| 08/13/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: HORMONE THERAPY | ||||||
| 08/05/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,591 | 4,420 | $527,309 | $223,240 |
| 2022 | 56 | 3,406 | 6,039 | $574,076 | $270,089 |
| 2021 | 46 | 3,750 | 8,700 | $725,035 | $374,449 |
| 2020 | 58 | 3,909 | 7,678 | $689,315 | $328,469 |
All Medicare Procedures & Services
198 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 501 | 849 | $122,066 | $79,824 | 65.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 20 | 162 | $113,400 | $21,890 | 19.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 69 | 88 | $35,750 | $16,639 | 46.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 130 | 146 | $24,090 | $15,651 | 65.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 100 | 184 | $18,400 | $11,966 | 65.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $17,550 | $9,827 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 127 | $13,228 | $8,830 | 66.7% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 29 | 30 | $17,295 | $8,801 | 50.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 24 | 120 | $8,400 | $5,887 | 70.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 70 | 119 | $16,879 | $4,503 | 26.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 335 | 517 | $15,518 | $4,236 | 27.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 29 | $26,100 | $3,892 | 14.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 49 | 57 | $5,700 | $3,645 | 63.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 146 | 196 | $6,860 | $3,518 | 51.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 30 | 31 | $9,300 | $3,450 | 37.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 11 | 11 | $7,700 | $2,730 | 35.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 14 | 14 | $7,000 | $2,626 | 37.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 537 | 1,037 | $6,222 | $2,259 | 36.3% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 21 | 21 | $10,500 | $2,220 | 21.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 25 | 34 | $5,950 | $2,035 | 34.2% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 15 | 42 | $6,300 | $1,932 | 30.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 27 | 58 | $2,610 | $1,450 | 55.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 98 | $2,744 | $1,062 | 38.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 15 | 15 | $4,875 | $720.00 | 14.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 22 | 36 | $8,105 | $716.04 | 8.8% |
About Dr. Gregory Mcintosh, D.O
Dr. Gregory Mcintosh, D.O is a Urology healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184688665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Mcintosh, D.O has received a total of $11,045 in payments from pharmaceutical and medical device companies, with $1,408 received in 2024. These payments were reported across 407 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($10,237).
As a Medicare-enrolled provider, Mcintosh has provided services to 13,656 Medicare beneficiaries, totaling 26,837 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 198 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Livonia, MI
- Active Since 04/13/2006
- Last Updated 10/03/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1184688665
Products in Payments
- XTANDI (Drug) $988.99
- Erleada (Drug) $847.37
- AMS (Device) $526.92
- FIRMAGON (Drug) $517.72
- UROLIFT (Device) $496.62
- BOTOX (Biological) $359.89
- ZYTIGA (Drug) $345.45
- ERLEADA (Drug) $315.25
- Myrbetriq (Drug) $303.01
- Xtandi (Drug) $242.38
- TITAN (Device) $231.84
- ORGOVYX (Drug) $228.62
- GEMTESA (Drug) $183.24
- ADSTILADRIN (Biological) $170.40
- Axumin (Drug) $168.32
- TOVIAZ (Drug) $159.57
- Xofigo (Drug) $156.94
- PROVENGE (Drug) $152.64
- Prolia (Biological) $147.51
- Porges Coloplast (Device) $147.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Livonia
William Johnston, Md, MD
Urology — Payments: $828,967
Dr. John Harb, Md, MD
Urology — Payments: $22,676
Dr. Jeffrey Schock, D.o, D.O
Urology — Payments: $13,939
Dr. Michael Hoff, D.o, D.O
Urology — Payments: $8,122
Dr. Benjamin Johnson, M.d, M.D
Urology — Payments: $6,026
Dr. Michael Macdonald, M.d, M.D
Urology — Payments: $661.74